Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01644253 |
Title | Phase 1b Safety and Efficacy Study of TRU-016 |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Aptevo Therapeutics |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Augusta | Georgia | 30912 | United States | Details | ||
Columbus | Ohio | 43210 | United States | Details | ||
Eastern Regional Medical Center | Philadelphia | Pennsylvania | 19124 | United States | Details | |
University of Pittsburgh | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
Greenville Health System | Greenville | South Carolina | 29605 | United States | Details | |
Houston | Texas | 77030 | United States | Details | ||
Swedish Cancer Institute,1221 Madison St. | Seattle | Washington | 98104 | United States | Details | |
Fred Hutchinson Cancer Research Center | Seattle | Washington | 98109 | United States | Details |